Skip to main content

Diagnostic options Β· UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 241–255 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4353
EMD Gene (Emery-Dreifuss Muscular Dystrophy Type 1) NGS Test

This test analyzes the entire EMD gene for mutations associated with Emery-Dreifuss muscular dystrophy type 1.

Peripheral whole blood (EDTA) or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EMD gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (Indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No special preparation is required."]
Indications
["Diagnosis of Emery-Dreifuss muscular dystrophy type 1", "Carrier status testing in at-risk family members", "Genetic counseling for families with EDMD1"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: G71.0
Clinical summary
This test analyzes the entire EMD gene for mutations associated with Emery-Dreifuss muscular dystrophy type 1.
TEST-6349
ENO3 Gene Glycogen Storage Disease Type 13 (GSD XIII) Genetic Test

This test evaluates the entire ENO3 gene for mutations associated with Glycogen Storage Disease Type 13 (GSD XIII). It identifies pathogenic variants, including single nucleotide v...

Peripheral Whole Blood (EDTA) or FTA Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ENO3 gene sequence", "Copy Number Variants (CNVs) in ENO3 gene"]
Parameters
[]
Preparation
["No special preparation such as fasting is required."]
Indications
["Suspected Glycogen Storage Disease Type 13", "Unexplained exercise intolerance", "Recurrent muscle cramps"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77784-8 ICD-10: E74.09
Clinical summary
This test evaluates the entire ENO3 gene for mutations associated with Glycogen Storage Disease Type 13 (GSD XIII). It identifies pathogenic variants, including single nucleotide variants, insertions/deletions, and copy number variations.
TEST-4081
ENPP1 Gene Arterial Calcification Type 1 (GACI) Genetic Test

This genetic test identifies pathogenic variants in the ENPP1 gene, confirming a diagnosis of Generalized Arterial Calcification of Infancy (GACI) type 1.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENPP1 gene"]
Parameters
[]
Preparation
["No fasting required.", "Pediatric phlebotomist will collect a small blood sample."]
Indications
["Infants with suspected GACI type 1", "Family history of GACI type 1", "Genetic counseling for at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88518-0 ICD-10: Q28.2
Clinical summary
This genetic test identifies pathogenic variants in the ENPP1 gene, confirming a diagnosis of Generalized Arterial Calcification of Infancy (GACI) type 1.
TEST-5314
ENPP1 Gene Cole Disease Genetic Test

This genetic test analyzes the ENPP1 gene for mutations associated with Cole disease.

Whole blood (EDTA), extracted DNA, or FTA card 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ENPP1 gene", "Coding regions and splice sites of the ENPP1 gene"]
Parameters
[]
Preparation
["No fasting required", "Complete a pre-test genetic counseling session", "Provide a detailed three-generation family pedigree"]
Indications
["Suspected Cole disease based on clinical presentation", "Family history suggestive of Cole disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98349-2 ICD-10: Q82.8, Z15.89, Z13.79
Clinical summary
This genetic test analyzes the ENPP1 gene for mutations associated with Cole disease.
TEST-6254
Enterokinase Deficiency (TMPRSS15 Gene) Genetic Test

This genetic test analyzes the entire coding sequence and CNVs of the TMPRSS15 gene to detect pathogenic variants causing congenital enterokinase deficiency.

Peripheral whole blood (2–5 mL in EDTA) or buccal swab (infants) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TMPRSS15 gene", "Single nucleotide variants (SNV)", "Small insertions/deletions (indel)", "Copy number variants (CNV)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the lab of any relevant family history."]
Indications
["Infants or children presenting with unexplained hypoproteinaemia, oedema, and growth faltering.", "Confirmation of suspected congenital enterokinase deficiency.", "Identification of pathogenic variants in the TMPRSS15 gene.", "Family planning for families with an affected child."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E88.89
Clinical summary
This genetic test analyzes the entire coding sequence and CNVs of the TMPRSS15 gene to detect pathogenic variants causing congenital enterokinase deficiency.
TEST-5432
EOGT Gene Adams-Oliver Syndrome Type 4 Genetic Test

This test identifies pathogenic variants in the EOGT gene associated with Adams-Oliver syndrome type 4.

Peripheral whole blood (or pre-extracted DNA) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EOGT gene", "Copy Number Variations (CNV) in the EOGT gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Clinical features suggestive of Adams-Oliver syndrome type 4", "Family history of Adams-Oliver syndrome type 4", "Genetic counselling recommendation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95887-3 ICD-10: Q87.2, Q84.8, Z13.79
Clinical summary
This test identifies pathogenic variants in the EOGT gene associated with Adams-Oliver syndrome type 4.
TEST-3287
EPAS1 Gene Erythrocytosis (Familial Type 4) Genetic Test

This test evaluates the EPAS1 gene for mutations associated with familial erythrocytosis type 4.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["EPAS1 gene sequence", "Copy Number Variations (CNV) in EPAS1"]
Parameters
[]
Preparation
["Detailed clinical history including prior hematological events and family history of erythrocytosis.", "Mandatory genetic counselling session to construct a pedigree chart."]
Indications
["Suspected familial erythrocytosis type 4", "Family screening for EPAS1 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: D75.0, D75.1, Z15.89
Clinical summary
This test evaluates the EPAS1 gene for mutations associated with familial erythrocytosis type 4.
TEST-6255
EPHX2 Gene Modifier Analysis for Familial Hypercholesterolemia (LDLR Defect) via NGS Test

This test analyzes the EPHX2 gene to identify variants that modify the severity and drug response associated with LDLR-related familial hypercholesterolemia.

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["EPHX2 gene variants", "Modifier effect on LDL receptor activity", "Cardiovascular risk prediction"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed lipid-lowering medication"]
Indications
["In-depth lipid disorder phenotyping", "Tailored statin or intensive therapy decisions", "Screening suspected familial hypercholesterolemia cases", "Risk prediction studies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88214-3 ICD-10: E78.01
Clinical summary
This test analyzes the EPHX2 gene to identify variants that modify the severity and drug response associated with LDLR-related familial hypercholesterolemia.
TEST-1055
Episodic Ataxia Type 2 Hotspot Test

This test identifies specific pathogenic mutations in the CACNA1A gene associated with Episodic Ataxia Type 2 (EA2). It is used for definitive diagnosis in patients presenting with...

Whole Blood (Lavender Top EDTA Tube, 2 mL min) 5 Business Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the CACNA1A gene", "Presence of known EA2 hotspot variants"]
Parameters
[]
Preparation
["No fasting required", "Collect 2 mL whole blood in a Lavender Top (EDTA) tube", "Refrigerate sample immediately", "Ship via temperature-controlled cold-chain logistics"]
Indications
["Clinical suspicion of Episodic Ataxia Type 2", "Documented family history of EA2", "Differential diagnosis of ataxia, vertigo, or migraine"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21631-6 ICD-10: G11.8
Clinical summary
This test identifies specific pathogenic mutations in the CACNA1A gene associated with Episodic Ataxia Type 2 (EA2). It is used for definitive diagnosis in patients presenting with characteristic symptoms.
TEST-3839
ESR1 Gene Estrogen Resistance Genetic Test

This genetic test identifies pathogenic variants in the ESR1 gene associated with estrogen resistance.

Peripheral Whole Blood 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ESR1 gene", "Estrogen receptor alpha gene mutations"]
Parameters
[]
Preparation
[]
Indications
["Family history of estrogen resistance", "Endocrinologists seeking personalised hormone therapy guidance", "Fertility specialists investigating unexplained infertility", "Anti-aging physicians exploring hormone optimisation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93026-2 ICD-10: Z15.89
Clinical summary
This genetic test identifies pathogenic variants in the ESR1 gene associated with estrogen resistance.
TEST-4399
ETHE1 Gene Ethylmalonic Encephalopathy Genetic Test

This test identifies pathogenic variants in the ETHE1 gene associated with ethylmalonic encephalopathy.

Whole Blood, Extracted DNA, Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ETHE1 gene coding exons", "ETHE1 gene conserved splice sites"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid blood collection during acute illness"]
Indications
["Suspected ethylmalonic encephalopathy", "Family history of ethylmalonic encephalopathy", "Unexplained neurological symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95207-8 ICD-10: E72.51
Clinical summary
This test identifies pathogenic variants in the ETHE1 gene associated with ethylmalonic encephalopathy.
TEST-3142
ETV6 Gene Thrombocytopenia Type 5 Genetic Test

This test evaluates the ETV6 gene for variants associated with hereditary thrombocytopenia type 5.

Peripheral whole blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)", "Full ETV6 gene sequence"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required", "Genetic counseling session recommended"]
Indications
["Suspected hereditary thrombocytopenia type 5", "Evaluation of bleeding risk", "Family history of ETV6-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76905-3 ICD-10: D69.41
Clinical summary
This test evaluates the ETV6 gene for variants associated with hereditary thrombocytopenia type 5.
TEST-5084
EXT1 Gene Exostoses, Multiple, Type 1 Test

This test evaluates the EXT1 gene for pathogenic variants associated with Hereditary Multiple Exostoses (Type 1). It identifies genetic mutations linked to the development of multi...

Whole blood (EDTA) or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EXT1 gene", "Copy Number Variations (CNV) in EXT1"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Confirmation of clinical diagnosis of Hereditary Multiple Exostoses (Type 1)", "Genetic counselling for families with HME", "Guiding surveillance strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q78.6
Clinical summary
This test evaluates the EXT1 gene for pathogenic variants associated with Hereditary Multiple Exostoses (Type 1). It identifies genetic mutations linked to the development of multiple benign bone tumors (osteochondromas).
TEST-5795
EYA1 Gene Branchiootic Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the EYA1 gene to diagnose Branchiootic Syndrome Type 1.

Whole Blood (EDTA, 3–5 mL) or Extracted DNA (β‰₯1 Β΅g, A260/A280: 1.8–2.0) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the EYA1 gene", "Full coding region + splice sites"]
Parameters
[{"name": "EYA1 Gene Analysis", "reference_range": "No pathogenic variants detected"}]
Preparation
["Discontinue high-dose biotin (>5 mg/day) supplementation 72 hours prior to blood draw."]
Indications
["Congenital ear anomalies", "Branchial cleft fistulae", "Preauricular tags", "Guiding otologic surgical planning", "Audiological rehabilitation", "Familial genetic risk stratification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94219-4 ICD-10: Q87.0
Clinical summary
This test identifies pathogenic variants in the EYA1 gene to diagnose Branchiootic Syndrome Type 1.
TEST-3835
F12 Gene (Factor XII Deficiency) Genetic Test

This genetic test evaluates the F12 gene for mutations associated with Factor XII deficiency and Hereditary Angioedema type III.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the F12 gene", "Carrier status for F12 gene mutations", "Risk for Hereditary Angioedema type III (HAE-FXII)"]
Parameters
[{"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Analytical Specificity", "reference_range": ">99.9%"}]
Preparation
["No specific fasting required", "Consult your doctor regarding medication adjustments"]
Indications
["Diagnosis of hereditary Factor XII deficiency", "Diagnosis of Hereditary Angioedema type III (HAE-FXII)", "Identification of carriers for F12 gene mutations", "Family screening for F12 gene mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-3 ICD-10: D68.2, E88.0
Clinical summary
This genetic test evaluates the F12 gene for mutations associated with Factor XII deficiency and Hereditary Angioedema type III.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certaintyβ€”book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.